- News Home
5 December 2013 11:26 am ,
Vol. 342 ,
An animal rights group known as the Nonhuman Rights Project filed lawsuits in three New York courts this week in an...
Researchers have been hot on the trail of the elusive Denisovans, a type of ancient human known only by their DNA and...
Thousands of scientists in the Russian Academy of Sciences (RAS) are about to lose their jobs as a result of the...
Dyslexia, a learning disability that hinders reading, hasn't been associated with deficits in vision, hearing, or...
Exotic, elusive, and dangerous, snakes have fascinated humankind for millennia. They can be hard to find, yet their...
Researchers have sequenced and analyzed the first two snake genomes, which represent two evolutionary extremes. The...
Snake venoms are remarkably complex mixtures that can stun or kill prey within minutes. But more and more researchers...
At age 30, Dutch biologist Freek Vonk has built up a respectable career as a snake scientist. But in his home country,...
- 5 December 2013 11:26 am , Vol. 342 , #6163
- About Us
Flu Research Moratorium Should Continue, Fauci Says
26 April 2012 5:36 pm
Although the contention over whether to publish two controversial H5N1 avian influenza studies appears to be waning, researchers should continue to abide by a voluntary moratorium on certain types of studies involving the virus, a senior U.S. science official said today.
There should be "an extension on the moratorium," which was originally supposed to expire on 20 March, Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) told a U.S. Senate panel today. "The question is for how long."
The comments came at a hearing held by the Committee on Homeland Security and Governmental Affairs into the risk posed by "dual use" research that carries both benefits and risks. The hearing was prompted, in large part, by the H5N1 controversy, said Senator Joseph Lieberman (I-CT), the chair of the panel. "Although this particular issue appears to have been resolved, it's going to recur and we can't just 'kick this can down the road' and deal with it on an ad hoc basis when it happens again."
Four witnesses, including Fauci, discussed the process that led to a decision by the National Science Advisory Board for Biosecurity (NSABB) to support publication of the two papers, and new U.S. government rules designed to identify taxpayer-funded dual use research of concern before it begins. They also responded to criticism of the NSABB process by one of the panel's members, Michael Osterholm of the University of Minnesota, Twin Cities, in a letter first obtained by ScienceInsider.
Look for more details on the hearing tomorrow on ScienceInsider.